These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33755692)

  • 1. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
    PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
    Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
    J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.
    Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
    Breast; 2020 Dec; 54():343-348. PubMed ID: 33023825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
    Posso M; Alcántara R; Vázquez I; Comerma L; Baré M; Louro J; Quintana MJ; Román M; Marcos-Gragera R; Vernet-Tomas M; Saladie F; Vidal C; Bargalló X; Peñalva L; Sala M; Castells X;
    Eur Radiol; 2022 Jan; 32(1):621-629. PubMed ID: 34156554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
    Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
    Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical model for identifying the short-term risk of breast cancer.
    Eriksson M; Czene K; Pawitan Y; Leifland K; Darabi H; Hall P
    Breast Cancer Res; 2017 Mar; 19(1):29. PubMed ID: 28288659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
    Castells X; Domingo L; Corominas JM; Torá-Rocamora I; Quintana MJ; Baré M; Vidal C; Natal C; Sánchez M; Saladié F; Ferrer J; Vernet M; Servitja S; Rodríguez-Arana A; Roman M; Espinàs JA; Sala M
    Breast Cancer Res Treat; 2015 Jan; 149(1):237-44. PubMed ID: 25503778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.
    Román M; Hofvind S; von Euler-Chelpin M; Castells X
    Br J Cancer; 2019 Jan; 120(2):269-275. PubMed ID: 30563993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.
    Blanch J; Sala M; Ibáñez J; Domingo L; Fernandez B; Otegi A; Barata T; Zubizarreta R; Ferrer J; Castells X; Rué M; Salas D;
    PLoS One; 2014; 9(10):e110207. PubMed ID: 25333936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
    Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
    Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
    Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
    Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
    Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
    Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.